Welcome to our dedicated page for Keycorp SEC filings (Ticker: KEY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
KeyCorp filings document the reporting, governance, and capital structure of a bank-based financial services company with common shares listed under KEY and multiple series of depositary preferred shares. Its 8-K filings include operating results, supplemental earnings materials, investor presentation disclosures, executive and board changes, and other material events.
Regulatory filings also cover proxy matters, director elections, executive compensation, shareholder voting items, and board structure. Capital-structure disclosures include registered securities, preferred stock depositary shares, senior medium-term notes, Form S-3 registration activity, and prospectus supplements tied to securities offerings.
Rankin Devina A reported acquisition or exercise transactions in this Form 4 filing.
KeyCorp director Devina A. Rankin reported a new equity award made as deferred compensation. She received 7,352 Deferred Shares, each economically equivalent to one Common Share, under KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp 2026 Equity Compensation Plan. Payment of these deferred shares has been postponed until January 1, 2031. Following these entries, she holds 13,430 Common Shares and 89,117 Deferred Shares directly.
KEYCORP director Christopher L. Henson reported a compensation-related award of 7,352 Deferred Shares. These Deferred Shares are economically equivalent to the company’s Common Shares and were granted under KeyCorp’s Amended and Restated Directors’ Deferred Share Sub-Plan of the KeyCorp 2026 Equity Compensation Plan.
Under the plan, Henson is scheduled to receive payment of the 7,352 Deferred Shares one-half as Common Shares and one-half in cash on May 14, 2029. Following the transactions reported, he also holds 250 Common Shares directly. The filing reflects a grant/award acquisition, not an open-market purchase or sale.
Gile Elizabeth R. reported acquisition or exercise transactions in this Form 4 filing.
KEYCORP director Elizabeth R. Gile received 7,352 Deferred Shares as a compensation award. Each Deferred Share is the economic equivalent of one Common Share and was granted under KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp 2026 Equity Compensation Plan.
Payment of these Deferred Shares has been deferred until October 1, 2029. Following this award, Gile now holds 132,059 Deferred Shares, including approximately 1,338 dividend-equivalent Deferred Shares accrued in March 2026, and 45,201 Common Shares directly. This is a routine, non-cash equity compensation transaction rather than an open-market trade.
Dallas H James reported acquisition or exercise transactions in this Form 4 filing.
KeyCorp director Dallas H. James reported a routine equity compensation grant. He received 7,352 Deferred Shares on Common Shares-equivalent terms under KeyCorp’s Amended and Restated Directors’ Deferred Share Sub-Plan of the KeyCorp 2026 Equity Compensation Plan.
Each Deferred Share is the economic equivalent of one Common Share. Under the plan, Mr. James will receive payment of these Deferred Shares one-half as Common Shares and one-half in cash on May 14, 2029. After these transactions, he holds 138,769 Common Shares directly and 26,777 Deferred Shares.
Tobin Richard J reported acquisition or exercise transactions in this Form 4 filing.
KeyCorp director Richard J. Tobin received an award of 7,352 Deferred Shares, each economically equivalent to one Common Share. Under the directors' Deferred Share Plan, these will be paid half in Common Shares and half in cash on May 14, 2029. After this award, he holds 84,896 Deferred Shares and 750 Common Shares directly.
VASOS TODD J reported acquisition or exercise transactions in this Form 4 filing.
KeyCorp director Todd J. Vasos reported updated holdings and a new equity award. He received a grant of 7,352 Deferred Shares, each economically equivalent to one Common Share, under KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp 2026 Equity Compensation Plan.
Payment of these Deferred Shares has been deferred until July 1, 2029. Following this award, Vasos directly holds 35,255 Common Shares and 75,450 Deferred Shares, reflecting both his share ownership and deferred equity-based compensation position.
KEYCORP /NEW/ director Antonio DeSpirito III filed an initial Form 3 showing his current equity stake in the company. The filing reports beneficial ownership of 4,450 Common Shares, held directly. This is a baseline disclosure of his holdings, not a report of a new trade.
KeyCorp director Christopher L. Henson has filed an initial statement of ownership on Form 3. The filing reports beneficial ownership of 250 Common Shares held directly. This is a disclosure of his current stake and does not report any recent share purchases or sales.
KeyCorp reported routine annual meeting results and new capital return actions. Shareholders elected fourteen directors, ratified Ernst & Young as auditor for 2026, approved executive compensation, and approved the 2026 Equity Compensation Plan, which allows a broad range of equity awards and raises the annual equity and cash compensation limit for non-employee directors from $500,000 to $750,000.
The board declared a quarterly cash dividend of $0.205 per common share for the second quarter of 2026, along with scheduled dividends on multiple preferred stock series, all payable on June 15, 2026. The board also authorized a new share repurchase program under which KeyCorp may repurchase up to $3.0 billion of common shares, replacing a prior $1.0 billion authorization that had approximately $280 million remaining.
KEYCORP director Richard J. Hipple reported compensation-related transactions involving Deferred Shares and Common Shares. On May 11, 2026, he exercised 18,118 Deferred Shares that were economically equivalent to Common Shares. According to the disclosure, 9,059 Deferred Shares were settled for cash based on a 30‑day average closing price, and the remaining 9,058 Deferred Shares were settled for an equal number of Common Shares. A related disposition entry shows 9,059 Common Shares transferred to the issuer at $21.41 per share, leaving Hipple with 104,575 Common Shares held directly. The position also reflects approximately 4,096 Common Shares from dividend reinvestments and 1,637 dividend‑equivalent Deferred Shares accrued between June 2025 and March 2026.